Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 23
Results/page:
12 3 > 
Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe
ID: 634453
Start date: 2015-06-01, End date: 2018-05-31
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single...
Programme: H2020-EU.3.1.2.
Record Number: 193289
Last updated on: 2017-09-11
European Human Biomonitoring Initiative
ID: 733032
Start date: 2017-01-01, End date: 2021-12-31
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts...
Programme: H2020-EU.3.1.2.
Record Number: 207219
Last updated on: 2017-08-17
Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria
ID: 733073
Start date: 2017-01-01, End date: 2021-12-31
Plasmodium vivax is the most widespread malaria and constitutes a significant proportion of human malaria cases. P. vivax accounts for 100-400 million clinical cases each year among the 2.5 billion people living at risk in Latin America, Oceania and Asia. The recently revised...
Programme: H2020-EU.3.1.2.
Record Number: 207218
Last updated on: 2017-04-19
Optimizing a deployable high efficacy malaria vaccine
ID: 733273
Start date: 2017-01-01, End date: 2021-12-31
A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vaccine technologies and antigen discovery approaches now make accelerated design and development of a highly effective multi-antigen...
Programme: H2020-EU.3.1.2.
Record Number: 207225
Last updated on: 2017-04-19
Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine
ID: 733176
Start date: 2017-01-01, End date: 2020-12-31
Rabies is the deadliest disease on earth (99.9% fatality rate). Annually, ~58.000 people die from rabies, more than half of them are children. Many remain unvaccinated because of the high costs and the need for a cold-chain. Likewise, despite the existence of an excellent...
Programme: H2020-EU.3.1.2.
Record Number: 207222
Last updated on: 2016-12-02
Crimean-Congo Haemorrhagic Fever Vaccine
ID: 732732
Start date: 2017-01-01, End date: 2022-12-31
Natural epidemics and outbreaks of emerging viral epidemics are growing problems internationally. The general aim of the CCHFVaccine project is to develop and deliver a vaccine, which can significantly increase our capacity to control the situation of Crimean Congo...
Programme: H2020-EU.3.1.2.
Record Number: 207211
Last updated on: 2017-06-02
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)
ID: 634935
Start date: 2015-09-01, End date: 2020-08-31
Breast cancer affects more than 360,000 women per year in the EU and causes more than 90,000 deaths. Identification of women at high risk of the disease can lead to disease prevention through intensive screening, chemoprevention or prophylactic surgery. Breast cancer risk is...
Programme: H2020-EU.3.1.2.
Record Number: 193315
Last updated on: 2017-06-16
Screening for Chronic Kidney Disease (CKD)  among Older People across Europe (SCOPE)
ID: 634869
Start date: 2015-05-01, End date: 2019-04-30
Chronic kidney disease (CKD) is an important public health problem worldwide, especially in older people. Indeed, population aging in industrialized countries is accompanied by an increase in the prevalence of CKD and its complications. Although its prevalence and the...
Programme: H2020-EU.3.1.2.
Record Number: 193309
Last updated on: 2017-09-11
EU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPE
ID: 634753
Start date: 2015-09-01, End date: 2020-08-31
Breast, colorectal and cervical cancer cause 250,000 deaths each year, representing 20% of EU-cancer mortality. Although important progress has been made in both detection and treatment, there is persisting inequity in progress to reduce its burden. Screening programmes vary...
Programme: H2020-EU.3.1.2.
Record Number: 193304
Last updated on: 2017-08-17
Female cancer prediction using cervical omics to individualise screening and prevention
ID: 634570
Start date: 2015-09-01, End date: 2019-08-31
While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for...
Programme: H2020-EU.3.1.2.
Record Number: 193298
Last updated on: 2017-07-31
12 3 > 
List retrieved on: 2017-11-25
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top